| Patent | Date |
|---|
Compositions and methods for unoccluded transdermal oxybutynin therapy
Grant 10,272,061 - Ebert , et al. | 2019-04-30 |
Compositions And Methods For Transdermal Oxybutynin Therapy
App 20170095438 - Ebert; Charles D. ; et al. | 2017-04-06 |
Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy
Grant 8,241,662 - Ebert , et al. August 14, 2 | 2012-08-14 |
Compositions and Methods for Transdermal Oxybutynin Therapy
App 20090018190 - Ebert; Charles D. ; et al. | 2009-01-15 |
Compositions and methods for transdermal oxybutynin therapy
App 20070148195 - Ebert; Charles D. ; et al. | 2007-06-28 |
Compositions and methods for transdermal oxybutynin therapy
Grant 7,179,483 - Ebert , et al. February 20, 2 | 2007-02-20 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
Grant 7,087,241 - Sanders , et al. August 8, 2 | 2006-08-08 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
Grant 7,081,249 - Sanders , et al. July 25, 2 | 2006-07-25 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
Grant 7,081,252 - Sanders , et al. July 25, 2 | 2006-07-25 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
Grant 7,081,251 - Sanders , et al. July 25, 2 | 2006-07-25 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
Grant 7,081,250 - Sanders , et al. July 25, 2 | 2006-07-25 |
Compositions and methods for transdermal oxybutynin therapy
Grant 7,029,694 - Ebert , et al. April 18, 2 | 2006-04-18 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
App 20060078613 - Sanders; Steven W. ; et al. | 2006-04-13 |
Compositions and methods for transdermal oxybutynin therapy
App 20050226898 - Ebert, Charles D. ; et al. | 2005-10-13 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
App 20050048107 - Sanders, Steven W. ; et al. | 2005-03-03 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
App 20050048106 - Sanders, Steven W. ; et al. | 2005-03-03 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
App 20040259954 - Sanders, Steven W. ; et al. | 2004-12-23 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
App 20040120996 - Sanders, Steven W. ; et al. | 2004-06-24 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
Grant 6,743,441 - Sanders , et al. June 1, 2 | 2004-06-01 |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
Grant 6,730,318 - Quan , et al. May 4, 2 | 2004-05-04 |
Compositions and methods for transdermal oxybutynin therapy
App 20030147926 - Ebert, Charles D. ; et al. | 2003-08-07 |
Compositions and methods for transdermal oxybutynin therapy
App 20030124177 - Ebert, Charles D. ; et al. | 2003-07-03 |
Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same
App 20030091620 - Fikstad, David ; et al. | 2003-05-15 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
App 20020147236 - Sanders, Steven W. ; et al. | 2002-10-10 |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
App 20020004064 - Quan, Danyi ; et al. | 2002-01-10 |
Antioxidant composition for topical/transdermal prevention and treatment of wrinkles
Grant 6,180,133 - Quan , et al. January 30, 2 | 2001-01-30 |
Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
Grant 5,985,317 - Venkateshwaran , et al. November 16, 1 | 1999-11-16 |
Buccal delivery of glucagon-like insulinotropic peptides
Grant 5,863,555 - Heiber , et al. January 26, 1 | 1999-01-26 |
Compositions and methods for buccal delivery of pharmaceutical agents
Grant 5,849,322 - Ebert , et al. December 15, 1 | 1998-12-15 |
Triacetin as a penetration enhancer for transdermal delivery of a basic drug
Grant 5,834,010 - Quan , et al. November 10, 1 | 1998-11-10 |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
Grant 5,783,208 - Venkateshwaran , et al. July 21, 1 | 1998-07-21 |
Buccal delivery of glucagon-like insulinotropic peptides
Grant 5,766,620 - Heiber , et al. June 16, 1 | 1998-06-16 |
Transdermal delivery system with adhesive overlay and peel seal disc
Grant 5,662,925 - Ebert , et al. September 2, 1 | 1997-09-02 |
Drug-containing adhesive composite transdermal delivery device
Grant 5,626,866 - Ebert , et al. May 6, 1 | 1997-05-06 |
Triacetin as a penetration enhancer for transdermal delivery of a basic drug
Grant 5,601,839 - Quan , et al. February 11, 1 | 1997-02-11 |
Transmucosal delivery of macromolecular drugs
Grant 5,516,523 - Heiber , et al. May 14, 1 | 1996-05-14 |
Methods for providing testosterone and optionally estrogen replacement therapy to women
Grant 5,460,820 - Ebert , et al. October 24, 1 | 1995-10-24 |
Transmucosal delivery of macromolecular drugs
Grant 5,346,701 - Heiber , et al. September 13, 1 | 1994-09-13 |
Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
Grant 5,302,395 - Ebert , et al. April 12, 1 | 1994-04-12 |
Sorbitan esters as skin permeation enhancers
Grant 5,227,169 - Heiber , et al. July 13, 1 | 1993-07-13 |
Sorbitan esters as skin permeation enhancers
Grant 5,212,199 - Heiber , et al. May 18, 1 | 1993-05-18 |
Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
Grant 5,164,190 - Patel , et al. November 17, 1 | 1992-11-17 |
Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
Grant 5,152,997 - Ebert , et al. October 6, 1 | 1992-10-06 |
Apparatus and method for noninvasive blood glucose monitoring
Grant 5,139,023 - Stanley , et al. August 18, 1 | 1992-08-18 |
Sorbitan esters as skin permeation enhancers
Grant 5,122,383 - Heiber , et al. June 16, 1 | 1992-06-16 |
Device for administering an active agent to the skin or mucosa
Grant 4,983,395 - Chang , et al. * January 8, 1 | 1991-01-08 |
Chitosan compositions for controlled and prolonged release of macromolecules
Grant 4,895,724 - Cardinal , et al. January 23, 1 | 1990-01-23 |
Method for reducing skin irritation associated with drug/penetration enhancer compositions
Grant 4,855,294 - Patel , et al. August 8, 1 | 1989-08-08 |
Transdermal administration of a systemic active agent to a premature neonatal infant
Grant 4,853,227 - Kurihara-Bergstrom , et al. August 1, 1 | 1989-08-01 |
Device for administering an active agent to the skin or mucosa
Grant 4,849,224 - Chang , et al. July 18, 1 | 1989-07-18 |
| 